Skip to main content
Top
Published in: Reactions Weekly 1/2017

01-04-2017 | Clinical study

Benefits and costs of screening prior to COCs underestimated

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Costs and benefits of thrombophilia screening to reduce the risk of venous thromboembolism (VTE) prior to prescribing combined oral contraceptives (COCs) have been underestimated in economic analyses, according to findings of a systematic review published in Applied Health Economics and Health Policy. …
Literature
Metadata
Title
Benefits and costs of screening prior to COCs underestimated
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-28091-9

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Clozapine

Case report

Sirolimus

Case report

Mitomycin

Case report

Temozolomide

Case report

Primaquine

Case report

Aripiprazole